SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened volatility as investors weigh strong quarterly earnings and robust revenue growth against management's plans for significantly increased capital expenditure. The stock is currently a major focal point for community debate, with bulls highlighting AI-driven demand and foundry expansion, while bears are expressing concerns over future dilution risks and broad semiconductor sector sentiment.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors focus on recent patent extensions that could secure exclusivity until 2041, driving a sharp surge in the share price to multi-year highs. The community is actively discussing analyst price target upgrades and a perceived shift in market sentiment that is forcing short sellers to cover positions amid significant volume.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as the stock faces continued downward pressure, with investors expressing significant frustration over stagnant performance and questioning the leadership of CEO Albert Bourla. Despite recent FDA approvals and a high dividend yield, the community remains divided between those viewing the current valuation as a bargain and those wary of long-term business fundamentals.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently at the center of investor focus as the market anticipates crucial 26-week durability data from its COMP006 trial, a key milestone that could significantly accelerate the path to FDA approval for its lead depression therapy. The community is actively discussing the stock's potential as a first-mover in the psychedelic space, with many investors debating the implications of potential sector-wide acquisition interest and the clinical validation of the drug's effectiveness compared to existing treatments.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing heightened market scrutiny as investors weigh its aggressive increase in AI infrastructure spending against strong cloud growth and earnings performance. The community is actively debating whether this massive capital expenditure represents a necessary investment to secure long-term market leadership or an unsustainable burden on free cash flow.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is trending as leveraged traders navigate extreme volatility and the asset's rapid decay, with the community actively debating whether current price levels represent a bargain or a potential value trap. Investors are closely monitoring geopolitical tensions, inflation data, and the influence of the US dollar on silver's price action as they look for signs of a sustained reversal.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA approval of Auvelity for the treatment of agitation associated with Alzheimers disease, a major milestone that positions the drug for significant market expansion. Investors and the community are actively discussing the implications of this 'clean' label, the company's raised peak sales guidance, and the potential for a rapid commercial ramp-up ahead of the upcoming earnings report.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing extreme volatility as investors debate whether the recent sharp price swings represent a structural top or a temporary consolidation within a larger gold bull market. The community is intensely focused on leveraging trend rail signals and macro indicators to navigate the fund's heavy daily price fluctuations, with many traders debating the risks of holding through market volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to an FDA advisory committee recommendation that could expand legal compounding access to popular peptides, a move the community views as a potential growth catalyst. Investors are actively debating the stock's future, balancing enthusiasm for this potential market expansion against volatility from short interest and ongoing skepticism regarding long-term regulatory outcomes.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor scrutiny due to high capital expenditure, debt concerns, and a recent credit downgrade, despite receiving a multi-billion dollar Pentagon contract. While some retail investors view the current price as a buying opportunity, community sentiment remains highly polarized between those anticipating a major turnaround based on cloud demand and those fearing continued downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BetterLife Pharma, Inc. is an emerging biotechnology company, which focuses on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. The firm owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.

BetterLife Pharma Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

BETRFBetterLife Pharma Inc

Fundamentals

Latest BETRF News